![]() |
시장보고서
상품코드
1618265
혈관 패치 : 시장 인사이트, 경쟁 상황, 시장 예측(-2030년)Vascular Patches - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
혈관 패치 시장 규모는 2024년부터 2030년까지 예측 기간 동안 연평균 7.37%의 CAGR로 성장할 것으로 예상됩니다.
혈관 패치 시장은 심방세동을 포함한 심혈관계 질환, 관상동맥질환(CAD)과 같은 만성질환의 증가, 다양한 혈관 패치의 가용성, 주요 기업들의 혁신적인 제품 개발 활동으로 인해 크게 성장하고 있으며, 예측 기간 동안에도 수요가 가속화될 것으로 예상됩니다. 예측 기간 동안에도 수요가 가속화될 것으로 예상됩니다.
혈관 패치 : 시장 역학
World Heart Report(2023)가 제공한 자료에 따르면, 2021년에는 전 세계적으로 5억 명 이상이 심혈관질환을 앓고 있는 것으로 보고되고 있습니다. 또한, American Heart Association(2023년)이 제공한 최근 데이터에 따르면, 2030년까지 전 세계적으로 1,200만 명 이상이 심방세동으로 고통받을 것으로 추정됩니다.
British Heart Foundation의 Global Heart &Circulatory Diseases Factsheet(2024)에 따르면, 전 세계적으로 약 2억 명이 CAD를 앓고 있습니다. 혈관 패치는 동맥 복원술, 내막 박리술, 동맥류 재건술 등의 시술에서 중요한 역할을 하며, 치료 결과를 개선하고 합병증을 최소화하는 등 현대 심혈관계 치료에 필수적인 역할을 하고 있습니다.
혈관 패치 재료 유형별로는 생물학적 혈관 패치 부문이 2023년 가장 큰 매출 비중을 차지했습니다. 이 제품 카테고리의 빠른 성장은 합성 대체품에 비해 우수한 생체적합성, 면역원성 감소, 장기적인 치료 결과의 개선에 기인합니다.
또한, 탈세포화 및 가교와 같은 조직 가공 기술의 발전으로 생물학적 패치의 내구성과 안전성 프로파일이 개선되어 복잡한 혈관 시술에 더욱 적합하게 되었습니다. 혈관 질환의 유병률 증가와 자연스럽고 반응성이 낮은 임플란트 재료에 대한 선호도가 높아짐에 따라, 생물학적 혈관 패치는 외과 의사들 사이에서 특히 고성능과 합병증을 최소화해야 하는 응용 분야에서 선호되는 선택이 되고 있습니다.
세계의 혈관 패치 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 시장 규모 추정 및 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
Vascular Patches Market by Material Type (Biologic Vascular Patches and Synthetic Vascular Patches), Application Type (Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, and Others), End-User (Hospital, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing instances of chronic cardiovascular conditions, rising product developmental activities globally
The vascular patches market is estimated to grow at a CAGR of 7.37% during the forecast period from 2024 to 2030. The vascular patches market is growing significantly due to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, coronary artery disease (CAD) with growing shift toward endovascular treatments, availability of a wide range of vascular patches, and innovative product developmental activities by leading companies that are expected to escalate the demand for vascular patches during the forecast period from 2024 to 2030.
Vascular Patches Market Dynamics:
As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to recent data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally.
According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are living with CAD around the world. Vascular patches play a vital role in procedures like arterial repairs, endarterectomy, and aneurysm reconstruction, offering improved outcomes and minimizing complications, making them indispensable in contemporary cardiovascular treatments. Hence the market for the same is increasing.
Increased product developmental activities by market key players across the globe is further expected to drive the market growth for vascular patches. For example, in May 2024, the consortium of Teijin Limited, Fukui Tateami Co., Ltd., and Osaka Medical and Pharmaceutical University announced that, SYNFOLIUM(R) a novel cardiovascular surgical patch, designed with a knitted fabric composed of both bio-absorbable and non-absorbable yarns, coated with cross-linked gelatin was scheduled for manufacturing and distribution from June 2024.
Therefore, the factors stated above collectively will drive the overall vascular patches market during the forecast period from 2024 to 2030.
However, availability of alternative options, stringent regulatory approval process, and others may limit their end-user base, thus acting as key constraints limiting the growth of the vascular patches.
Vascular Patches Market Segment Analysis:
Vascular Patches Market by Material Type (Biologic Vascular Patches and Synthetic Vascular Patches), Application Type (Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, and Others), End-User (Hospital, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the material type segment of vascular patches, the biologic vascular patch category is expected to have a significant revenue share in the year 2023. The rapid growth of this product category is growing due to its superior biocompatibility, reduced immunogenicity, and enhanced long-term outcomes compared to synthetic alternatives.
Biologic patches, derived from materials like bovine pericardium or porcine-derived tissues, offer excellent tissue integration and remodeling properties, minimizing complications such as thrombosis, calcification, or infection. Their natural structure supports endothelialization, which is critical for vascular healing and maintaining patency in arterial and venous reconstructions.
Additionally, advancements in tissue processing techniques, such as decellularization and crosslinking, have improved the durability and safety profiles of biologic patches, making them more suitable for complex vascular procedures. With the increasing prevalence of vascular diseases and a growing preference for natural and less reactive implant materials, biologic vascular patches are becoming a preferred choice among surgeons, especially in applications requiring high performance and minimal complications.
Therefore, owing to all the above-mentioned factors, the demand for the biologic vascular patch category is expected to witness considerable growth eventually contributing to the overall growth of the vascular patches market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall vascular patches market:
Among all the regions, North America is expected to dominate the vascular patches market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. The increasing prevalence of cardiovascular conditions such as coronary artery disease (CAD), myocardial infarction, and peripheral artery disease (PAD), along with rising comorbidities like hypertension and hyperlipidemia, combined with significant advancements in product development and regulatory approvals, and the presence of well- established and sophisticated infrastructure is expected to drive the market for vascular patches during the forecast period from 2024 to 2030.
As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure, among others. Some of the key risk factors associated with heart diseases are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.
According to data from the Canadian Institute for Health Information (2024), it stated that in 2022, 2.4 million Canadians were affected by heart disease.
As per data from the American Heart Association, 2021, PAD affected about 8.5 million U.S. adults over the age of 40, in 2021. As per the same source, African Americans are more likely to screen positive for PAD than non-Hispanic adults.
Vascular patches are critical in surgical interventions, offering improved vessel repair, reduced complications, and enhanced long-term outcomes, thereby bolstering the market for same.
Rising product launches and commercialization agreements among key manufacturers and other companies are anticipated to boost the market. For instance, in June 2021, Axio Biosolutions announced FDA 510(k) clearance of its hemostatic product Axiostat Patch, which helps control moderate to severe bleeding in vascular procedures.
Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North American region in the vascular patches market.
Vascular Patches Market key players:
Some of the key market players operating in the vascular patches market include B. Braun Melsungen AG, Baxter, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates, Inc., CryoLife, Inc, Aziyo, Medtrade Products Ltd, Collagen Solutions Plc, FOC Medical S.A., Anteris, Medtronic, Labcor Laboratorios, BD, Johnson & Johnson Services, Inc., Axio Biosolutions, and others.
Recent Developmental Activities in the Vascular Patches Market:
Key Takeaways from the Vascular Patches Market Report Study
Target audience who can be benefited from this vascular patches Market Report Study
Frequently Asked Questions for the Vascular Patches Market: